Insight

Photo of Martin Kaiser from icr.ac.uk

Aug 24, 2024, 12:58

Martin Kaiser: BSH/UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma

The Institute of Cancer Research, shared a post on LinkedIn:

“Happy to highlight the British Society of Haematology BSH / UK Myeloma Society UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma.

It is written with access challenges for patients to diagnostics and treatments in mind and can hopefully support access discussions in this context.

Also, it opens a future perspective on a route to safer treatment de-escalation for non-high-risk myeloma patients through comprehensive baseline diagnostics.”

Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper

Authors: Martin Kaiser, Guy Pratt, Ceri Bygrave, Kristian Bowles, Simon Stern, Matthew Jenner, and the BSH Committee.

Martin Kaiser: BSH/UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma

Source:

cancer Ceri Bygrave Guy Pratt high-risk myeloma Kristian Bowles Martin Kaiser Matthew Jenner OncoDaily Oncology ritish Society of Haematology Simon Stern the BSH Committee UK Myeloma Society

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology